C2729 - Overview: Breast Carcinoma-Associated Antigen (CA 27.29), Serum

Test Catalog

Test Name

Test ID: C2729    
Breast Carcinoma-Associated Antigen (CA 27.29), Serum

Useful For Suggests clinical disorders or settings where the test may be helpful

FDA-approved cancer-associated antigen (CA 27.29) for serial testing in women with prior stage II or III breast cancer who are clinically free of disease


Predicting early recurrence of disease in women with treated carcinoma of the breast


As an indication that additional tests or procedures should be performed to confirm recurrence of breast cancer

Method Name A short description of the method used to perform the test

Chemiluminometric Immunoassay

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.


Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

Breast Carcinoma Assoc Ag(CA 27.29)

Aliases Lists additional common names for a test, as an aid in searching

Biomira Truquant BR
Breast Cancer Tumor Markers
Breast Carcinoma
Cancer Antigen 27.29 (CA 27.29)
Milk Mucin